Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992981priorityCriticalpatent/ECSP992981A/en
Publication of ECSP992981ApublicationCriticalpatent/ECSP992981A/en
Composiciones que contienen inhibidor de ACE estabilizadas mediante la presencia de óxido de magnesio. Preferentemente, el inhibidor de ACE, quinapril, es protegido de ciertas formas de degradación cuando se prepara en una composición farmacéutica compuesta esencialmente por óxido de magnesio como el agente estabilizador. La presencia de óxido de magnesio también se presta para condiciones de procesamiento favorables durante la fabricación de las composiciones que contienen inhibidor de ACE, especialmente procesamiento mediante granulación en medio húmedo.Compositions containing ACE inhibitor stabilized by the presence of magnesium oxide. Preferably, the ACE inhibitor, quinapril, is protected from certain forms of degradation when prepared in a pharmaceutical composition consisting essentially of magnesium oxide as the stabilizing agent. The presence of magnesium oxide also lends itself to favorable processing conditions during the manufacture of ACE inhibitor-containing compositions, especially processing by wet granulation.
antimicrobial compositions comprising a natural agent selected from gallic acid, eucalipotol, naringin, a jasminic acid compound and any combination thereof